Semaglutide SELECT Study: No News Is News
ConscienHealth,
Sometimes the hardest news to digest is no news. This was certainly the case yesterday for Novo Nordisk, the market leader in…
Sometimes the hardest news to digest is no news. This was certainly the case yesterday for Novo Nordisk, the market leader in…
As I observed in my last column, fewer and fewer new biomedical words can be found in the Oxford English Dictionary (OED) as we…
Friday marked an important milestone in progress toward better treatments for obesity. Novo Nordisk submitted semaglutide to…
In February, the manufacturer of the weight-loss medication lorcaserin (Belviq, Belviq XR) voluntarily withdrew the drug from…